Get started
Author

Angelo Ranieri

Observed names: A Ranieri, A. Ranieri, Ranieri, Angelo
ORCID: 0000-0001-5450-1909
Observed ORCID: 0000-0001-5450-1909
OpenAlex ID: A5038696687
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
2021 · for the GARLIT Study Group, Fabrizio Vernieri, et al. · The Journal of Headache and Pain · 139
PDF
A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis
2005 · R. De Simone, E. Marano, et al. · Neurological Sciences · 89
Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis
2010 · Roberto De Simone, Angelo Ranieri, et al. · Neurological Sciences · 82
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study
2021 · Fabrizio Vernieri, Claudia Altamura, et al. · European Journal of Neurology · 69
Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy : The multicenter prospective cohort GARLIT study
2022 · Fabrizio Vernieri, Nicoletta Brunelli, et al. · European Journal of Neurology · 61
Intracranial pressure in unresponsive chronic migraine
2014 · Roberto De Simone, Angelo Ranieri, et al. · Journal of Neurology · 55
PDF
Migraine and epilepsy: clinical and pathophysiological relations
2007 · R. De Simone, A. Ranieri, et al. · Neurological Sciences · 53
Hypnic headache: an update
2006 · R. De Simone, E. Marano, et al. · Neurological Sciences · 49
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study
2023 · Piero Barbanti, Gabriella Egeo, et al. · The Journal of Headache and Pain · 48
PDF
Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing - Remitting Multiple Sclerosis
2020 · Giorgia T. Maniscalco, Mario Annunziata, et al. · Multiple Sclerosis and Related Disorders · 47
Starling resistors, autoregulation of cerebral perfusion and the pathogenesis of idiopathic intracranial hypertension
2017 · Roberto De Simone, Angelo Ranieri, et al. · Panminerva Medica · 46
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
2022 · Raffaele Ornello, Carlo Baraldi, et al. · The Journal of Headache and Pain · 45
PDF
Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine
2019 · Roberto De Simone, Angelo Ranieri, et al. · Neurological Sciences · 45
Cranial neuralgias: from physiopathology to pharmacological treatment
2008 · Roberto De Simone, Angelo Ranieri, et al. · Neurological Sciences · 45
The role of dural sinus stenosis in idiopathic intracranial hypertension pathogenesis: the self-limiting venous collapse feedback-loop model.
2014 · R De Simone, A Ranieri, et al. · PubMed · 43
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children
2014 · Roberto De Simone, Angelo Ranieri, et al. · Neurology · 36
PDF
Narrative Medicine to integrate patients’, caregivers’ and clinicians’ migraine experiences: the DRONE multicentre project
2021 · Maria Clara Tonini, Alessandra Fiorencis, et al. · Neurological Sciences · 32
PDF
Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?
2010 · Roberto De Simone, Angelo Ranieri, et al. · Neurological Sciences · 32
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience
2022 · Claudia Altamura, Nicoletta Brunelli, et al. · Journal of Neurology · 31
PDF
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men
2021 · Raffaele Ornello, Carlo Baraldi, et al. · Frontiers in Neurology · 29
The role of intracranial hypertension in the chronification of migraine
2015 · R. De Simone, A. Ranieri · Neurological Sciences · 28
GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures
2025 · Piero Barbanti, Gabriella Egeo, et al. · The Journal of Headache and Pain · 27
PDF
High prevalence of bilateral transverse sinus stenosis-associated IIHWOP in unresponsive chronic headache sufferers: Pathogenetic implications in primary headache progression
2011 · Roberto De Simone, Angelo Ranieri, et al. · Cephalalgia · 27
PDF
Endolymphatic hydrops in idiopathic intracranial hypertension: prevalence and clinical outcome after lumbar puncture. Preliminary data
2017 · Angelo Ranieri, Michele Cavaliere, et al. · Neurological Sciences · 23
Sinus venous stenosis-associated IIHWOP is a powerful risk factor for progression and refractoriness of pain in primary headache patients: a review of supporting evidences
2011 · Roberto De Simone, A. Ranieri, et al. · Neurological Sciences · 21
Works count: 71
Citation count: 1,482
H-index: 23
I10-index: 40
Year
Topic
Type